BIOBUSINESS BRIEFS

Novel drug targets in 2018

Computational and Structural Chemistry, Merck & Co., Boston, MA, USA.

Search for this author in:

Computational and Structural Chemistry, Merck & Co., Boston, MA, USA.

Search for this author in:

Department of Internal Medicine, Comprehensive Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Contact

Search for this author in:

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Nature Reviews Drug Discovery 18, 328 (2019)

doi: 10.1038/d41573-019-00052-5

This article is the first in a series from the NIH Common Fund Illuminating the Druggable Genome (IDG) program. The goal of IDG is to catalyse research on understudied proteins from druggable gene families by providing reagents, phenotypes and a mineable database; focusing on GPCRs, kinases and ion channels. For more information, see https://druggablegenome.net/

Competing Financial Interests

The authors declare no competing interests.

Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.